Skip to main content
Top
Published in: Acta Diabetologica 5/2016

Open Access 01-10-2016 | Original Article

Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes

Authors: Vladan M. Ninkovic, Srdjan M. Ninkovic, Vanja Miloradovic, Dejan Stanojevic, Marijana Babic, Vojislav Giga, Milan Dobric, Michael I. Trenell, Nebojsa Lalic, Petar M. Seferovic, Djordje G. Jakovljevic

Published in: Acta Diabetologica | Issue 5/2016

Login to get access

Abstract

Aims

Prolonged QT interval is associated with cardiac arrhythmias and sudden death. The present study determined the prevalence of prolonged QT interval and QT dispersion and defined their clinical and metabolic predictors in patients with type 2 diabetes.

Methods

Cross-sectional study included 501 patients with type 2 diabetes. A standard 12-lead electrocardiogram was recorded. QT corrected for heart rate (QTc) >440 ms and QT dispersion (QTd) >80 ms were considered abnormally prolonged. QTc ≥ 500 ms was considered a high-risk QTc prolongation. Demographic, clinical and laboratory data were collected. Independent risk factors for prolonged QTc and QTd were assessed using logistic regression analysis.

Results

Prevalence of QTc > 440 ms and QTd > 80 ms were 44.1 and 3.6 %, respectively. Prevalence of high-risk QTc (≥500 ms) was 2 % only. Independent risk factors for QTc prolongation >440 ms were mean blood glucose (β = 2.192, p < 0.001), treatment with sulphonylurea (β = 5.198, p = 0.027), female gender (β = 8.844, p < 0.001), and coronary heart disease (β = 8.636, p = 0.001). Independent risk factors for QTc ≥ 500 ms were coronary heart disease (β = 4.134, p < 0.001) and mean blood glucose level (β = 1.735, p < 0.001). The independent risk factor for prolonged QTd was only coronary heart disease (β = 5.354, p < 0.001).

Conclusions

Although the prevalence of prolonged QTc > 440 ms is significant, the prevalence of high-risk QTc (≥500 ms) and QTd > 80 ms is very low in patients with type 2 diabetes. Hyperglycaemia and coronary heart disease are strong predictors of high-risk QTc.
Literature
1.
go back to reference Schwartz PJ, Wolf S (1978) QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 57:1074–1077CrossRefPubMed Schwartz PJ, Wolf S (1978) QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 57:1074–1077CrossRefPubMed
2.
go back to reference Barr CS, Naas A, Freeman M, Lang CC, Struthers AD (1994) QT dispersion and sudden unexpected death in chronic heart failure. Lancet 343:327–329CrossRefPubMed Barr CS, Naas A, Freeman M, Lang CC, Struthers AD (1994) QT dispersion and sudden unexpected death in chronic heart failure. Lancet 343:327–329CrossRefPubMed
3.
go back to reference Veglio M, Sivieri R, Chinaglia A, Scaglioni L, Cavallo-Perin P (2000) QT interval prolongation and mortality in type 1 diabetic patients. Diabetes Care 23:1381–1383CrossRefPubMed Veglio M, Sivieri R, Chinaglia A, Scaglioni L, Cavallo-Perin P (2000) QT interval prolongation and mortality in type 1 diabetic patients. Diabetes Care 23:1381–1383CrossRefPubMed
4.
go back to reference Naas AA, Davidson NC, Thompson C et al (1998) QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study. BMJ 316(7133):745–746CrossRefPubMedPubMedCentral Naas AA, Davidson NC, Thompson C et al (1998) QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study. BMJ 316(7133):745–746CrossRefPubMedPubMedCentral
5.
go back to reference Schwartz PJ, Stramba-Badiale M, Segantini A et al (1998) Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 338:1709–1714CrossRefPubMed Schwartz PJ, Stramba-Badiale M, Segantini A et al (1998) Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 338:1709–1714CrossRefPubMed
6.
go back to reference Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J (1991) QT interval prolongation predicts cardiovascular mortality in an apparent healthy population. Circulation 84:1516–1523CrossRefPubMed Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J (1991) QT interval prolongation predicts cardiovascular mortality in an apparent healthy population. Circulation 84:1516–1523CrossRefPubMed
7.
go back to reference Elming H, Holm E, Jun L et al (1998) The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J 19:1391–1400CrossRefPubMed Elming H, Holm E, Jun L et al (1998) The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J 19:1391–1400CrossRefPubMed
8.
go back to reference Prineas RT, Crow RS, Blackburn H (1982) The minnesota code manual of electrocardiographic findings. Laboratory of Physiological Hygiene, School of Public Health, University of Minnesota, Minneapolis Prineas RT, Crow RS, Blackburn H (1982) The minnesota code manual of electrocardiographic findings. Laboratory of Physiological Hygiene, School of Public Health, University of Minnesota, Minneapolis
9.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470CrossRefPubMed Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470CrossRefPubMed
10.
go back to reference Ward DE (1988) Prolongation of the QT interval as an indicator of risk of a cardiac event. Eur Heart J 7:139–144CrossRef Ward DE (1988) Prolongation of the QT interval as an indicator of risk of a cardiac event. Eur Heart J 7:139–144CrossRef
11.
go back to reference Bazett HC (1920) An analysis of time-relations of electrocardiograms. Hearts. 7:353–370 Bazett HC (1920) An analysis of time-relations of electrocardiograms. Hearts. 7:353–370
12.
go back to reference Priori SG, Napolitano C, Diehl L, Schwartz PJ (1994) Dispersion of QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation 89:1681–1689CrossRefPubMed Priori SG, Napolitano C, Diehl L, Schwartz PJ (1994) Dispersion of QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation 89:1681–1689CrossRefPubMed
13.
go back to reference Service FJ, Molnar GD, Rosevear JW, Mackerman E, Gatewood LC, Taylor WF (1970) Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19:644–655CrossRefPubMed Service FJ, Molnar GD, Rosevear JW, Mackerman E, Gatewood LC, Taylor WF (1970) Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19:644–655CrossRefPubMed
14.
go back to reference Monnier L, Lapinski H, Colette C (2003) Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients. Variations with increasing levels of HbA1c. Diabet Care 26:3881–3885CrossRef Monnier L, Lapinski H, Colette C (2003) Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients. Variations with increasing levels of HbA1c. Diabet Care 26:3881–3885CrossRef
15.
go back to reference Moss AJ, Schwartz PJ, Crampton RS et al (1991) The long QT syndrome. Prospective longitudinal study of 328 families. Circulation 84:1136–1144CrossRefPubMed Moss AJ, Schwartz PJ, Crampton RS et al (1991) The long QT syndrome. Prospective longitudinal study of 328 families. Circulation 84:1136–1144CrossRefPubMed
16.
go back to reference Priori SG, Schwartz PJ, Napolitano C et al (2003) Risk stratification in the long-QT syndrome. N Engl J Med 348:1866–1874CrossRefPubMed Priori SG, Schwartz PJ, Napolitano C et al (2003) Risk stratification in the long-QT syndrome. N Engl J Med 348:1866–1874CrossRefPubMed
18.
go back to reference Goldenberg I, Mathew J, Moss AJ et al (2006) Corrected QT variability in serial electrocardiograms in long QT syndrome: the importance of the maximum corrected QT for risk stratification. J Am Coll Cardiol 48:1047–1052CrossRefPubMed Goldenberg I, Mathew J, Moss AJ et al (2006) Corrected QT variability in serial electrocardiograms in long QT syndrome: the importance of the maximum corrected QT for risk stratification. J Am Coll Cardiol 48:1047–1052CrossRefPubMed
19.
go back to reference Christensen PK, Gall MA, Major-Pedersen A et al (2000) QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes. Scand J Clin Lab Invest 60:323–332CrossRefPubMed Christensen PK, Gall MA, Major-Pedersen A et al (2000) QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes. Scand J Clin Lab Invest 60:323–332CrossRefPubMed
20.
go back to reference Veglio M, Bruno G, Borra M et al (2002) Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort. J Intern Med 251:317–324CrossRefPubMed Veglio M, Bruno G, Borra M et al (2002) Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort. J Intern Med 251:317–324CrossRefPubMed
21.
go back to reference Kumar R, Fisher M, Whitaker R, Macfarlane PW (2004) Effect of controlling hyperglycemia with diet on QT abnormalities in newly diagnosed patients with type 2 diabetes. Diabet Care 27:2767–2768CrossRef Kumar R, Fisher M, Whitaker R, Macfarlane PW (2004) Effect of controlling hyperglycemia with diet on QT abnormalities in newly diagnosed patients with type 2 diabetes. Diabet Care 27:2767–2768CrossRef
22.
go back to reference Li X, Ren H, Zhang-rong X, Liu Y-j, Yang X-p, Liu J-q (2012) Prevalence and risk factors of prolonged QTc interval among Chinese patients with type 2 diabetes. Exp Diabet Res 2012:234084. doi:10.1155/2012/234084 Li X, Ren H, Zhang-rong X, Liu Y-j, Yang X-p, Liu J-q (2012) Prevalence and risk factors of prolonged QTc interval among Chinese patients with type 2 diabetes. Exp Diabet Res 2012:234084. doi:10.​1155/​2012/​234084
23.
go back to reference Ewing DJ, Martyn CN, Young RJ, Clarke BF (1985) The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabet Care 8:491–498CrossRef Ewing DJ, Martyn CN, Young RJ, Clarke BF (1985) The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabet Care 8:491–498CrossRef
24.
go back to reference Asbury AK, Genuth SM, Griffin J et al (1988) Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy: American Diabetes Association and American Academy of Neurology (Consensus Statement). Diabet Care 11:592–597 CrossRef Asbury AK, Genuth SM, Griffin J et al (1988) Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy: American Diabetes Association and American Academy of Neurology (Consensus Statement). Diabet Care 11:592–597 CrossRef
25.
go back to reference Bravenboer B, Hendriksen PH, Oey LP, Gispen WH, van Huffelen AC, Erkelens DW (1993) Is the corrected QT interval a reliable indicator of the severity of diabetic autonomic neuropathy? Diabet Care 16(9):1249–1253CrossRef Bravenboer B, Hendriksen PH, Oey LP, Gispen WH, van Huffelen AC, Erkelens DW (1993) Is the corrected QT interval a reliable indicator of the severity of diabetic autonomic neuropathy? Diabet Care 16(9):1249–1253CrossRef
26.
go back to reference Valensi PE, Johnson NB, Maison-Blanche P, Extramania F, Motte G, Coumel P (2002) Influence of cardiac autonomic neuropathy on heart rate dependence of ventricular repolarization in diabetic patients. Diabet Care 25(5):918–923CrossRef Valensi PE, Johnson NB, Maison-Blanche P, Extramania F, Motte G, Coumel P (2002) Influence of cardiac autonomic neuropathy on heart rate dependence of ventricular repolarization in diabetic patients. Diabet Care 25(5):918–923CrossRef
27.
go back to reference Whitsel EA, Boyko EJ, Siscovick DS (2000) Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes: a meta-analysis. Diabet Care 23(2):241–247CrossRef Whitsel EA, Boyko EJ, Siscovick DS (2000) Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes: a meta-analysis. Diabet Care 23(2):241–247CrossRef
28.
go back to reference Cardoso C, Salles G, Bloch K, Deccache W, Siqueira-Filho AG (2001) Clinical determinants of increased QT dispersion in patients with diabetes mellitus. Int J Cardiol 79(2–3):253–262CrossRefPubMed Cardoso C, Salles G, Bloch K, Deccache W, Siqueira-Filho AG (2001) Clinical determinants of increased QT dispersion in patients with diabetes mellitus. Int J Cardiol 79(2–3):253–262CrossRefPubMed
29.
go back to reference Festa A, D’Agostino R, Rautaharju P, Mykkänen L, Haffner SM (2000) Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects. Am J Cardiol 86(10):1117–1122CrossRefPubMed Festa A, D’Agostino R, Rautaharju P, Mykkänen L, Haffner SM (2000) Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects. Am J Cardiol 86(10):1117–1122CrossRefPubMed
30.
go back to reference Takebayashi K, Aso Y, Sugita R, Takemura Y, Inukai T (2002) Clinical usefulness of corrected QT intervals in diabetic autonomic neuropathy in patients with type 2 diabetes. Diabet Metab 28(2):127–132 Takebayashi K, Aso Y, Sugita R, Takemura Y, Inukai T (2002) Clinical usefulness of corrected QT intervals in diabetic autonomic neuropathy in patients with type 2 diabetes. Diabet Metab 28(2):127–132
31.
go back to reference Fiorentini A, Perciaccante R, Valente R, Paris A, Serra P, Tubani L (2010) The correlation among QTc interval, hyperglycaemia and the impaired autonomic activity. Auton Neurosci 154(1–2):94–98CrossRefPubMed Fiorentini A, Perciaccante R, Valente R, Paris A, Serra P, Tubani L (2010) The correlation among QTc interval, hyperglycaemia and the impaired autonomic activity. Auton Neurosci 154(1–2):94–98CrossRefPubMed
32.
go back to reference Kazumi T, Kawaguchi A, Katoh JI, Ikeda Y, Kishi K, Yoshino G (1999) Fasting serum insulin concentrations are associated with QTc duration independent of serum leptin, percent body fat, and BMI. Diabet Care 22(11):1917–1918CrossRef Kazumi T, Kawaguchi A, Katoh JI, Ikeda Y, Kishi K, Yoshino G (1999) Fasting serum insulin concentrations are associated with QTc duration independent of serum leptin, percent body fat, and BMI. Diabet Care 22(11):1917–1918CrossRef
33.
go back to reference Subbalakshmi NK, Adhikari PM, Sathyanarayana Rao KN, Jeganathan PS (2010) Influencing factors of QTc among the clinical characteristics in type 2 diabetes mellitus. Diabet Res Clin Pract 88(3):265–272CrossRef Subbalakshmi NK, Adhikari PM, Sathyanarayana Rao KN, Jeganathan PS (2010) Influencing factors of QTc among the clinical characteristics in type 2 diabetes mellitus. Diabet Res Clin Pract 88(3):265–272CrossRef
34.
go back to reference Takebayashi K, Sugita R, Tayama K, Aso Y, Takemura Y, Inukai T (2003) The connection between QT dispersion and autonomic neuropathy in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 111(6):351–357CrossRefPubMed Takebayashi K, Sugita R, Tayama K, Aso Y, Takemura Y, Inukai T (2003) The connection between QT dispersion and autonomic neuropathy in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 111(6):351–357CrossRefPubMed
35.
go back to reference Sakabe K, Fukuda N, Fukuda Y et al (2008) QT-interval dispersion in type 2 diabetic and non-diabetic patients with post-myocardial infarction. Nutr Metab Cardiovasc Dis 18(2):121–126CrossRefPubMed Sakabe K, Fukuda N, Fukuda Y et al (2008) QT-interval dispersion in type 2 diabetic and non-diabetic patients with post-myocardial infarction. Nutr Metab Cardiovasc Dis 18(2):121–126CrossRefPubMed
36.
go back to reference Tesfamariam B, Brown ML, Cohen RA (1991) Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest. 87:1647–1648CrossRef Tesfamariam B, Brown ML, Cohen RA (1991) Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest. 87:1647–1648CrossRef
37.
go back to reference Gupta S, Sussman I, McArthur CS, Tomheim K, Cohen RA, Ruderman NB (1992) Endothelium-dependent Inhibition of Na+-K+ ATPase activity in rabbit aorta by hyperglicemia. Possible role of endothelium-derived nitric oxide. J Clin Invest. 90:727–732CrossRefPubMedPubMedCentral Gupta S, Sussman I, McArthur CS, Tomheim K, Cohen RA, Ruderman NB (1992) Endothelium-dependent Inhibition of Na+-K+ ATPase activity in rabbit aorta by hyperglicemia. Possible role of endothelium-derived nitric oxide. J Clin Invest. 90:727–732CrossRefPubMedPubMedCentral
38.
go back to reference Davis FB, Davis PJ, Nat G et al (1985) The effect of in vivo glucose administration on human erythrocyte Ca2+ -ATPase activity and on enzyme responsiveness in vitro to thyroid hormone and calmodulin. Diabetes 34(7):639–646CrossRefPubMed Davis FB, Davis PJ, Nat G et al (1985) The effect of in vivo glucose administration on human erythrocyte Ca2+ -ATPase activity and on enzyme responsiveness in vitro to thyroid hormone and calmodulin. Diabetes 34(7):639–646CrossRefPubMed
39.
go back to reference Lefrandt JD, Diercks GF, van Boven AJ, Crijns HJ, van Gilst WH, Gans RO (2000) High fasting glucose and QTc duration in a large healthy cohort. Diabetologia 43(10):1332–1334PubMed Lefrandt JD, Diercks GF, van Boven AJ, Crijns HJ, van Gilst WH, Gans RO (2000) High fasting glucose and QTc duration in a large healthy cohort. Diabetologia 43(10):1332–1334PubMed
40.
go back to reference Brown DW, Giles WH, Greenlund KJ, Valdez R, Croft JB (2001) Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. J Cardiovasc Risk 8:227–233CrossRefPubMed Brown DW, Giles WH, Greenlund KJ, Valdez R, Croft JB (2001) Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. J Cardiovasc Risk 8:227–233CrossRefPubMed
41.
go back to reference Marfella R, Nappo F, De Angelis L, Siniscalchi M, Rossi F, Giugliano D (2000) The effect of acute hyperglycaemia on QTc duration in healthy man. Diabetologia 43(5):571–575CrossRefPubMed Marfella R, Nappo F, De Angelis L, Siniscalchi M, Rossi F, Giugliano D (2000) The effect of acute hyperglycaemia on QTc duration in healthy man. Diabetologia 43(5):571–575CrossRefPubMed
42.
go back to reference Gordin D, Forsblom C, Rönnback M, Groop PH (2008) Acute hyperglycaemia disturbs cardiac repolarization in Type 1 diabetes. Diabet Med 25(1):101–105CrossRefPubMed Gordin D, Forsblom C, Rönnback M, Groop PH (2008) Acute hyperglycaemia disturbs cardiac repolarization in Type 1 diabetes. Diabet Med 25(1):101–105CrossRefPubMed
43.
go back to reference Najeed SA, Khan IA, Molnar J, Somberg JC (2002) Differential effect of glyburide (glibenclamide) and metformin on QT dispersion: a potential adenosine triphosphate sensitive K+ channel effect. Am J Cardiol 90(10):1103–1106CrossRefPubMed Najeed SA, Khan IA, Molnar J, Somberg JC (2002) Differential effect of glyburide (glibenclamide) and metformin on QT dispersion: a potential adenosine triphosphate sensitive K+ channel effect. Am J Cardiol 90(10):1103–1106CrossRefPubMed
44.
go back to reference Merri M, Benhorin J, Alberti M, Locati E, Moss AJ (1989) Electrocardiographic quantitation of ventricular repolarization. Circulation 80(5):1301–1308CrossRefPubMed Merri M, Benhorin J, Alberti M, Locati E, Moss AJ (1989) Electrocardiographic quantitation of ventricular repolarization. Circulation 80(5):1301–1308CrossRefPubMed
45.
go back to reference Stramba-Badiale M, Locati EH, Martinelli A, Courville J, Schwartz PJ (1997) Gender and the relationship between ventricular repolarization and cardiac cycle length during 24-h Holter recordings. Eur Heart J 18(6):1000–1006CrossRefPubMed Stramba-Badiale M, Locati EH, Martinelli A, Courville J, Schwartz PJ (1997) Gender and the relationship between ventricular repolarization and cardiac cycle length during 24-h Holter recordings. Eur Heart J 18(6):1000–1006CrossRefPubMed
46.
go back to reference Peters RW, Byington RP, Barker A, Yusuf S (1990) BHAT, Study Group11a. Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. J Clin Epidemiol 43(2):167–172CrossRefPubMed Peters RW, Byington RP, Barker A, Yusuf S (1990) BHAT, Study Group11a. Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. J Clin Epidemiol 43(2):167–172CrossRefPubMed
47.
go back to reference Dekker JM, Crow RS, Hannan PJ, Schouten EG, Folsom AR (2004) Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: the ARIC study. J Am Coll Cardiol 43(4):565–571CrossRefPubMed Dekker JM, Crow RS, Hannan PJ, Schouten EG, Folsom AR (2004) Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: the ARIC study. J Am Coll Cardiol 43(4):565–571CrossRefPubMed
48.
go back to reference Mirbolouk F, Arami S, Salari A, Shad B, Kazemnejad E, Moladoust H (2014) Corrected QT-interval and dispersion after revascularization by percutaneous coronary intervention and coronary artery bypass graft surgery in chronic ischemia. J Invasive Cardiol 26(9):444–450PubMed Mirbolouk F, Arami S, Salari A, Shad B, Kazemnejad E, Moladoust H (2014) Corrected QT-interval and dispersion after revascularization by percutaneous coronary intervention and coronary artery bypass graft surgery in chronic ischemia. J Invasive Cardiol 26(9):444–450PubMed
49.
go back to reference Yan GX, Yamada KA, Kleber AG, McHowat J, Corr PB (1993) Dissociation between cellular K+ loss, reduction in repolarization time, and tissue ATP levels during myocardial hypoxia and ischemia. Circ Res 72:560–570CrossRefPubMed Yan GX, Yamada KA, Kleber AG, McHowat J, Corr PB (1993) Dissociation between cellular K+ loss, reduction in repolarization time, and tissue ATP levels during myocardial hypoxia and ischemia. Circ Res 72:560–570CrossRefPubMed
50.
go back to reference Rana BS, Band MM, Ogston S, Morris AD, Pringle SD, Struthers AD (2002) Relation of QT interval dispersion to the number of different cardiac abnormalities in diabetes mellitus. Am J Cardiol 90:483–487CrossRefPubMed Rana BS, Band MM, Ogston S, Morris AD, Pringle SD, Struthers AD (2002) Relation of QT interval dispersion to the number of different cardiac abnormalities in diabetes mellitus. Am J Cardiol 90:483–487CrossRefPubMed
Metadata
Title
Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes
Authors
Vladan M. Ninkovic
Srdjan M. Ninkovic
Vanja Miloradovic
Dejan Stanojevic
Marijana Babic
Vojislav Giga
Milan Dobric
Michael I. Trenell
Nebojsa Lalic
Petar M. Seferovic
Djordje G. Jakovljevic
Publication date
01-10-2016
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 5/2016
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-016-0864-y

Other articles of this Issue 5/2016

Acta Diabetologica 5/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.